How priming affects the development of memory T cells in the intestines

Impact of priming on the generation of intestinal tissue-resident memory T cells

NIH-funded research State University New York Stony Brook · NIH-10886637

This study is looking at how certain signals in the body can help create special immune cells in the intestines that fight infections and tumors, with the goal of developing better vaccines that boost your immune protection where it's needed most.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionState University New York Stony Brook NIH-funded
Lab location1 site (Stony Brook, United States)
Project IDNIH-10886637 on NIH RePORTER

What this research studies

This research investigates the mechanisms that influence the development of tissue-resident memory CD8 T cells in the intestines, which are crucial for effective immune responses against infections and tumors. The study focuses on how priming signals, particularly from retinoic acid, can enhance the differentiation of these memory T cells in the gut. By understanding these processes, the research aims to improve vaccination strategies that can generate robust immune responses at sites of pathogen invasion or tumor growth. Patients may benefit from insights that could lead to more effective vaccines tailored to enhance intestinal immunity.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions that affect the gastrointestinal tract or those at risk for gastrointestinal infections or tumors.

Not a fit: Patients with non-gastrointestinal conditions or those who do not have a significant immune response issue may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to improved vaccines that generate stronger immune responses in the intestines, potentially reducing the risk of infections and tumors.

How similar studies have performed: Previous research has shown promise in understanding T cell development, but this specific approach focusing on intestinal memory T cells is relatively novel.

Where this research is happening

Stony Brook, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.